Results 51 - 67 from 67 for "antibiotice iasi"
-
Antibiotice Iasi 1Q Profit Down 26% To RON5.3M, Turnover Up 1% To RON55.4M
05.15.2017
-
Antibiotice Iasi To Pay Dividends At A 4% Yield From 2016 Profit
03.06.2017
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will pay dividends of RON0.023/share from 2016 profit, at a 4.1% yield, the company said in a statement to Bucharest Stock Exchange Monday. more
-
SIF Oltenia Buys 780,000 Shares In Antibiotice Iasi For RON395,000
12.15.2016
-
Antibiotice Iasi Ceases Payment Of 2012 Dividends As Of November
10.17.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will cease the payment of dividends from 2012 profit as of November 1, 2016, the company said in a statement Monday. more
-
Ioan Nani, Antibiotice Iasi: Clawback Tax Became A Drawback For Drugmakers
10.02.2016
The medicine industry is more and more affected by the clawback tax, as the tax currently accounts for approximately 30% of the value added of a drugmaker, which will soon lead to the collapse of drug more
-
Antibiotice Iasi Sales Up 9% In January-June
08.01.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported sales of RON143.8 million in January-June 2016, up 9% from the year-earlier period. more
-
Antibiotice Iasi 1Q Profit Up 18% To RON7.1M
05.17.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a profit of RON7.1 million in January-March 2016, up 18% from the year-earlier period. more
-
Antibiotice Iasi Suspends Pay Of Remaining Dividends For 2011's Profit
09.16.2015
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Tuesday said on the Bucharest Stock Exchange it will suspend the payment of the dividends due for 2011 and not cashed by the stockholders, on more
-
Antibiotice Iasi Extends RON60M Loan Into 2015
06.26.2014
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will extend by one year its 60 million lei (some EUR13 million) credit line signed with EximBank in July 2013, according to a shareholders’ more
-
Antibiotice Iasi, Set To Near EUR100M In Revenue In 2016
05.01.2014
Antibiotice Iasi (ATB.RO) plans to boost revenue by stepping up exports and launching new products. The company ranks 11th among the biggest players on the Romanian pharmaceutical market. more
-
Antibiotice Iasi: Exports Reach 30% Of 2013 Sales
12.29.2013
Health Ministry-owned drug producer Antibiotice Iasi (ATB.RO) estimates this year's exports to amount to more than $26 million or 30% of its total sales. more
-
Antibiotice And Biofarm, Among Most Profitable Stock Investments
10.03.2013
The shares of drug producers Antibiotice Iasi (ATB.RO) and Biofarm Bucuresti (BIO.RO) generated over 50% profits in the past year, including the dividends paid to shareholders, which makes them some more
-
Ioan Nani: Antibiotice Iasi Can Grow Into A Regional Player With Help From An Investor
09.23.2013
Romania’s state-run drugmaker Antibiotice Iasi can grow to become a player in the region, but with support from an investor and improved legislation, the company’s general manager Ioan Nani said more
-
Antibiotice Iasi 1H Sales Down 4% To RON142M
08.06.2013
Sales of Romanian state-run drug maker Antibiotice Iasi (ATB.RO) declined 4% in the first half of the year, to RON141.8 million (EUR32.3 million), and its net profit dropped 37%, to RON16.1 million more
-
Antibiotice Takes EUR11.3M Credit Line For Working Capital
06.21.2012
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) took two credit lines of EUR9.5 million and 8 million lei (EUR1.8 million) to finance its working capital, the company said in a statement sent more
-
Antibiotice Proposes RON17.2M Share Capital Hike
03.23.2012
The managing board of Romanian state-owned medicine maker Antibiotice Iasi (ATB.RO) increased to 17.2 million lei (EUR3.9 million) the sum proposed to stockholders as share capital hike, according to more
-
Antibiotice To Sell Medicine Worth RON68M Through Pharma Iasi
09.06.2011
Romanian medicine maker Antibiotice Iasi (ATB.RO) on Tuesday corrected to 68 million lei (EUR16 million), from RON50 million, the value of the medicine sale contract inked with wholesaler Phama Iasi. more